Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;8(1):69-75.
doi: 10.15171/apb.2018.009. Epub 2018 Mar 18.

Effect of Onopordon acanthium L. as Add on Antihypertensive Therapy in Patients with Primary Hypertension Taking Losartan: a Pilot Study

Roshanak Ghods  1   2 , Manouchehr Gharouni  3 , Massoud Amanlou  4 , Niusha Sharifi  4 , Ali Ghobadi  1   2 , Gholamreza Amin  5
Affiliations

Effect of Onopordon acanthium L. as Add on Antihypertensive Therapy in Patients with Primary Hypertension Taking Losartan: a Pilot Study

Roshanak Ghods et al. Adv Pharm Bull. 2018 Mar.

Abstract

Purpose: Onopordon acanthium L. is known for its medicinal properties. Our recent study showed that its seed extract is a novel natura angiotensin-converting-enzyme inhibitor (ACEI). This study was carried out to investigate its possible antihypertensive effects in patients receiving losartan. Methods: This uncontrolled clinical trial was carried out among 20 patients (30-60y) with uncontrolled hypertension despite receiving 50 mg losartan (stage I & II) in two hospitals in Iran. After completing informed consent, patients were treated by 2 capsules [each 1g of Onopordon acanthium seed extract (OSE)] as add-on therapy, two times per day. Results: 18 patients completed the study (50.94 ±8.37y). Mean systolic blood pressure (SBP) at the baseline was 151.9 ± 13.74mmHg and at the end of the study, it was 134.6 ± 18.25 mmHg and mean diastolic blood pressure (DBP) was 97.41 ± 10.36 at the baseline and was 85.71 ± 7.481 after 8 weeks. OSE significantly reduced SBP and DBP at the end of 8 weeks (P=0.003, 95% CI: -19.7, -15.1; P=0.0006, 95% CI: -10.23, -13.15; respectively). No evidence of hepatic or renal toxicity was detected. Conclusion: Based on the results of this study OSE has antihypertensive property with no significant adverse effects. However, because of the low number of samples, this medication may be not safely administered. The results of this study could be the basis for further studies with larger sample size. IRCT registration number: IRCT2013020712391N.

Keywords: Angiotensin converting enzyme; Blood pressure; Hypertension; Onopordon acanthium L; Persian medicine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
Figure 4
Figure 4
Figure 5
Figure 5
See this image and copyright information in PMC

References

    1. Chockalingam A. Impact of world hypertension day. Can J Cardiol. 2007;23(7):517–9. doi: 10.1016/S0828-282X(07)70795-X. - DOI - PMC - PubMed
    1. Chockalingam A. World hypertension day and global awareness. Can J Cardiol. 2008;24(6):441–4. doi: 10.1016/S0828-282X(08)70617-2. - DOI - PMC - PubMed
    1. Sever PS, Messerli FH. Hypertension management 2011: Optimal combination therapy. Eur Heart J. 2011;32(20):2499–506. doi: 10.1093/eurheartj/ehr177. - DOI - PubMed
    1. Kalra S, Kalra B, Agrawal N. Combination therapy in hypertension: An update. Diabetol Metab Syndr. 2010;2:44. doi: 10.1186/1758-5996-2-44. - DOI - PMC - PubMed
    1. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF. et al. Guidelines for management of hypertension: Report of the fourth working party of the british hypertension society, 2004-bhs iv. J Hum Hypertens. 2004;18(3):139–85. doi: 10.1038/sj.jhh.1001683. - DOI - PubMed

LinkOut - more resources